Cowa, LLC Merck & Co., Inc. Transaction History

Cowa, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $49,520 - $53,184	400 Added 25.69%	1,957 $244 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $176,314 - $205,446	1,557 New	1,557 $205 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $29,749 - $33,194	-289 Reduced 12.94%	1,945 $206,000
Q4 2022 Jan 27, 2023	BUY	$87.44 - $112.11 $87 - $112	1 Added 0.04%	2,234 $0
Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $188,755 - $212,045	2,233 New	2,233 $192,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $11.6 Million - $13 Million	158,265 New	158,265 $130,000
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $67,286 - $74,425	-957 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $68,683 - $76,225	957 New	957 $79,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cowa, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowa, LLC with notifications on news.